Molecular diagnostic strategies in prion disease

Prion diseases are fatal neurodegenerative and infectious disorders characterized by structural transition of the host-encoded cellular prion protein into the aberrantly folded pathologic isoform of the protein. Here is the latest research on molecular diagnostic strategies for prion diseases.

February 10, 2018
Open Access

Chronic wasting disease management in ranched elk using rectal biopsy testing

Prion
Nicholas J HaleyBruce Thomsen
July 12, 2019
Open Access

Detection of Cell-Free Mitochondrial DNA in Cerebrospinal Fluid of Creutzfeldt-Jakob Patients

Frontiers in Neurology
Jie LiLifeng Yang
June 24, 2020

Diagnosis of Prion Diseases by RT-QuIC Results in Improved Surveillance

Neurology
Daniel D RhoadsBrian S Appleby
September 20, 2019

National Variability in Prion Disease-Related Safety Policies for Neurologic Procedures

The Neurohospitalist
Katherine WerbanethCarl A Gold
December 14, 2019
Review
Open Access

Retinal correlates of neurological disorders

Therapeutic Advances in Chronic Disease
Timothy E YapM Francesca Cordeiro
December 11, 2019
Open Access

Use of different RT-QuIC substrates for detecting CWD prions in the brain of Norwegian cervids

Scientific Reports
Edoardo BistaffaFabio Moda
January 27, 2020

Diagnostics of sporadic creutzfeldt-jakob disease – literature review

Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
Wojciech Maciej CiepierskiKrzysztof Wierzcbicki
April 7, 2020
Case Report

A case of MV2K subtype of sporadic Creutzfeldt-Jakob disease with florid-like plaques: Similarities and differences to variant Creutzfeldt-Jakob disease

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Matic BošnjakMara Popović
April 23, 2019
Review

Human prion diseases

Current Opinion in Infectious Diseases
Han WangBrian S Appleby
June 30, 2019

Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification

Laboratory Investigation; a Journal of Technical Methods and Pathology
Manuel V CamachoSilvio Notari
April 18, 2018
Open Access

Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid

The Journal of Pathology. Clinical Research
Marcelo A BarriaMark W Head
July 7, 2020
Open Access

Insects in food and feed - allergenicity risk assessment and analytical detection

EFSA Journal
German Federal Institute for Risk Assessment (BfR), National Reference Laboratory for Animal protein in Feed, NRL‐APAlbert Braeuning
April 15, 2019
Open Access

Transmission of prion infectivity from blood by peptoid-conjugated beads

BioRxiv : the Preprint Server for Biology
Simone HornemannAdriano Aguzzi
April 6, 2019
Open Access

Tissue inhibitor of metalloproteinase-1 and interleukin-10 in serum from naïve and scrapie infected sheep

Veterinary and Animal Science
Marta G SilvaDonald P Knowles
January 18, 2019
Open Access

Early preclinical detection of prions in the skin of prion-infected animals

Nature Communications
Zerui WangWen-Quan Zou
April 22, 2020

Atypical and Early Symptoms of sporadic Creutzfeldt - Jakob Disease: Case series and review of the literature

The International Journal of Neuroscience
Grammatiki KatsikakiSevasti Bostantjopoulou
January 17, 2020
Open Access

The 19th Rocky Mountain Virology Association Meeting

Viruses
Joel RovnakRandall J Cohrs
May 12, 2020

Proteomics in Neurodegenerative Disease

Current Protein & Peptide Science
Nidhi PuranikJun-O Jin

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/molecular-diagnostic-strategies-in-prion/ef69aa0e-036b-4e7b-8880-6bb4ec200bcd